Jazz Pharmaceuticals Announces FDA Acceptance and Priority Review of Supplemental NDA for Xywav™ Oral Solution
Jazz Pharmaceuticals plc today announced that the U.S. Food and Drug Administration (FDA) has granted Priority ...
Read more
Tag: Jazz
Jazz Pharmaceuticals Announces FDA Approval of Additional Indication for Vyxeos® (daunorubicin and cytarabine)
Jazz Pharmaceuticals plc announced that the U.S. Food and Drug Administration (FDA) approved a revised label ...
Read more